Manual Of Hypertension Of The European Society Of Hypertension Third Edition

The Manual of Hypertension of the European Society of Hypertension reflects emerging concepts that have the potential to impact diagnostic and therapeutic approaches to hypertension. Updating all material, this new edition also delves into a number of areas that have received heightened interest in recent years or have become a matter of debate due to the controversial interpretation of the available data. FEATURES Reflects emerging concepts impacting diagnostic and therapeutic approaches Explores background, history, epidemiology, and risk factors Describes pharmacological, nonpharmacological, and medical treatments Examines hypertension in special populations and treatment

The European Society of Hypertension Guidelines are imparted throughout the text in order for the reader to achieve 'better practice.' The data provided is all evidence-based and clearly referenced. Professor Guiseppe Mancia is a leading light on the management and treatment of hypertension and is particularly expert on the angiotensin II recept

Despite recent advances in healthcare, hypertension is a leading cause of death and remains a disease burden worldwide. Now in its second edition, the Manual of Hypertension of the European Society of Hypertension reflects emerging concepts that have the potential to impact diagnostic and therapeutic approaches to this condition. Updating all mater

A clinical manual on hypertension for primary care physicians. Serves as an up-to-date reference on hypertension for use in clinical practice. Includes dozens of clear and informative tables and figures to maximize comprehension. Addresses the most recent and crucial developments in a very common chronic condition. Gives a comprehensive review of currently available medications and combination therapy. Approximately one billion people worldwide are affected by hypertension. About 24% of the adult population in the US are hypertensive, and the number is expected to increase with the rising rates of obesity and diabetes. As hypertension affects so many and spans across varying ages, genders, ethnicities, and socioeconomic classes, all clinicians are likely to encounter patients with hypertension on regular basis. Hypertension is one of the major causes of cardiovascular diseases, and timely diagnosis and treatment are essential. The manual will give the reader a thorough overview of antihypertensive lifestyle modifications, first-line therapy, combination therapies, comorbid conditions, therapeutic challenges, and the latest trends in antihypertensive therapy. Pharmaceutical companies can use this clinician’s manual as an excellent educational giveaway, as the booklet includes the latest clinical research results and treatment options for hypertension. The manual will give the reader a thorough overview of antihypertensive lifestyle modifications, first-line therapy, combination therapies, comorbid conditions, therapeutic challenges, and the latest trends in antihypertensive therapy. Pharmaceutical companies can use this clinician’s manual as an excellent educational giveaway, as the booklet includes the latest clinical research results and treatment options for hypertension. The manual will give the reader a thorough overview of antihypertensive lifestyle modifications, first-line therapy, combination therapies, comorbid conditions, therapeutic challenges, and the latest trends in antihypertensive therapy. Pharmaceutical companies can use this clinician’s manual as an excellent educational giveaway, as the booklet includes the latest clinical research results and treatment options for hypertension. Approximately one billion people worldwide are affected by hypertension. About 24% of the adult population in the US are hypertensive, and the number is expected to increase with the rising rates of obesity and diabetes. As hypertension affects so many and spans across varying ages, genders, ethnicities, and socioeconomic classes, all clinicians are likely to encounter patients with hypertension on regular basis. Hypertension is one of the major causes of cardiovascular diseases, and timely diagnosis and treatment are essential. The manual will give the reader a thorough overview of antihypertensive lifestyle modifications, first-line therapy, combination therapies, comorbid conditions, therapeutic challenges, and the latest trends in antihypertensive therapy. Pharmaceutical companies can use this clinician’s manual as an excellent educational giveaway, as the booklet includes the latest clinical research results and treatment options for hypertension. The manual will give the reader a thorough overview of antihypertensive lifestyle modifications, first-line therapy, combination therapies, comorbid conditions, therapeutic challenges, and the latest trends in antihypertensive therapy. Pharmaceutical companies can use this clinician’s manual as an excellent educational giveaway, as the booklet includes the latest clinical research results and treatment options for hypertension. The manual will give the reader a thorough overview of antihypertensive lifestyle modifications, first-line therapy, combination therapies, comorbid conditions, therapeutic challenges, and the latest trends in antihypertensive therapy. Pharmaceutical companies can use this clinician’s manual as an excellent educational giveaway, as the booklet includes the latest clinical research results and treatment options for hypertension. Approximately one billion people worldwide are affected by hypertension. About 24% of the adult population in the US are hypertensive, and the number is expected to increase with the rising rates of obesity and diabetes. As hypertension affects so many and spans across varying ages, genders, ethnicities, and socioeconomic classes, all clinicians are likely to encounter patients with hypertension on regular basis. Hypertension is one of the major causes of cardiovascular diseases, and timely diagnosis and treatment are essential. The manual will give the reader a thorough overview of antihypertensive lifestyle modifications, first-line therapy, combination therapies, comorbid conditions, therapeutic challenges, and the latest trends in antihypertensive therapy. Pharmaceutical companies can use this clinician’s manual as an excellent educational giveaway, as the booklet includes the latest clinical research results and treatment options for hypertension. The manual will give the reader a thorough overview of antihypertensive lifestyle modifications, first-line therapy, combination therapies, comorbid conditions, therapeutic challenges, and the latest trends in antihypertensive therapy. Pharmaceutical companies can use this clinician’s manual as an excellent educational giveaway, as the booklet includes the latest clinical research results and treatment options for hypertension. The manual will give the reader a thorough overview of antihypertensive lifestyle modifications, first-line therapy, combination therapies, comorbid conditions, therapeutic challenges, and the latest trends in antihypertensive therapy. Pharmaceutical companies can use this clinician’s manual as an excellent educational giveaway, as the booklet includes the latest clinical research results and treatment options for hypertension.

Hypertension has become a major public health hazard not only in industrialized nations, but also in emerging economies. Early detection combined with effective treatment is imperative to reduce the risk of patients developing premature cardiovascular disease and accelerated atherosclerosis. A clear, concise resource, Hypertension: A Clinical Guide

The Pocket Book is for use by doctors nurses and other health workers who are responsible for the care of young children at the first level referral hospitals. This second edition is based on evidence from several WHO updated and published clinical guidelines. It is for use in both inpatient and outpatient care in small hospitals with basic laboratory facilities and essential medicines. In some settings these guidelines can be used in any facilities where sick children are admitted for inpatient care. The Pocket Book is one of a series of documents and tools that support the Integrated Managem.

Endorsed by the American Society for Preventive Cardiology, this highly practical resource focuses on the application of current guidelines and practice standards in the clinical management of cardiovascular risk factors. The Manual presents concise descriptions of each major cardiovascular risk factor, and practical, to-the-point discussions of current best practices in clinical management. In addition, the Manual includes chapters on peripheral arterial disease, stroke, smoking, contemporary cardiovascular imaging, heart failure, metabolic syndrome, thrombosis, nutrition, special populations, novel risk factors, and psychosocial stress. Throughout the Manual, recommendations are based on the most recent prevention guidelines of the American College of Cardiology and American Heart Association, including those on Risk Assessment, Lifestyle Recommendations, Blood Cholesterol, and Obesity, as well as the new guidelines on Hypertension. Chapter authors are recognized leaders in each area of practice, and special efforts have been made by the authors and editors to ensure that the content of all chapters is as up-to-date as possible. Key Features: ■ Presents a highly practical focus on the application of current guidelines and practice standards regarding cardiovascular risk factors ■ Recommendations based on the most recent prevention guidelines ■ Authored by recognized leaders in the field ■ Covers all major cardiovascular risk factors, key methodologies in risk assessment, and special issues regarding specific patient populations